KLRC1 and neoplasm: Of note, optimum control of tumor growth was achieved when NK cells were injected in conjunction with the dual combination of anti‐NKG2A/Qa‐1b mAbs, but not when combined with anti‐Qa‐1b or anti‐NKG2A separately (Fig EV1).